The global D-dimer testing market size was valued at US$ 1.23 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing is driving the global D-dimers market.The D-dimer test is used to find out if the patient is suffering from blood clotting disorder. The clotting of blood is very important, if the blood is not clotted, it may ooze out and the patient suffers from heavy blood loss. The leftovers floating in the blood is called D-dimer, excessive clotting may lead to coagulation of D-dimers in the blood vein which can cause serious issues and can be fatal. D-dimers are widely used for the exclusion of VTE.
The global D-dimer Testing market is expected to grow during the forecast period because of growing opportunities of various cardiovascular disorders, rising incidences of pulmonary disease, heat strokes, the growing demands for advanced coagulation testing techniques and cost effectiveness of the tests. Because of the sedentary lifestyle and unhealthy eating habits, there is a rapid increase in the cardiovascular and pulmonary diseases these days which leads to hike in the demand of D-dimers. There is a shortage of radiological interventions, and D-dimers are cost-effective, and highly accurate which marks its huge demand across the globe. Elevated D-dimer level serves as a great helper in the several tests for cardiac diseases as well as other diseases. Aptamers are not that costly and even low-income people can afford it, it is more stable and inexpensive to produce, and it has more shelf-life in comparison to antibodies, and is really helpful in the D-dimer testing, hence there is a huge demand of Aptamers on the global D-dimer testing market. AYASS Bioscience LLC first developed Aptamers.
The factors which produce hurdle in the global D-dimers market are high level of competitors as well as the efficiency of the test as sometimes the testing doesn’t go well and the patient can suffer side-effects and injuries. Advancements in technologies such as the development of next-generation Point-of-Care (PoC) D-dimer testing solutions, are providing new opportunities in the global D-dimer testing market. The D-dimer testing market is challenged by several factors like the cost-effectiveness, side-effects, enlargement in the number of competitors and others.
The global D-dimer testing market can be categorized on the basis of Test-type, Product, Method, Application and End-User. Test-type is further sub-segmented into Clinical Laboratory Tests and Point-of-Care Tests. The Product segment is further sub-segmented into Analyzers and Reagents &Consumables. Method type is further classified into Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immunoturbidimetric Assays and Fluorescence Immunoassays. Application segment is further classified into Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and Disseminated Intravascular Coagulation (DIC). End user is further sub-segmented into Hospitals, Academic and Research Institutes, Diagnostic Centers and others. A rise in Venous Thromboembolism, pulmonary and cardiac diseases play a vital role in the increased demand of D-dimers.
Most of the laboratories use compression ultrasound and pretest probability which makes the D-dimer testing even more demanding. The ELISA (enzyme linked immuno sorbent assays), is most commonly used in D-dimers testing because it is faster, convenient, automated and highly sensitive method. It had the most of revenue share of around 36%.The Deep vein Thrombosis is a medical case which often catches those immobile hospitalized patients and its mostly un-diagnosed which makes the patient weak this is why the DVT segment is highly in demand and it marked a revenue share of about 37% in 2019.
Based on Geography, the global D-dimer market is segmented into North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA). Currently, North America dominates the global D-dimers market. Currently North America is ruling the global D-dimers market. Over 90,000 people are affected with WTE each year and about 60,000-100,000 Americans suffer from VTE each year, leading to high demand of the D-dimers test.
The companies ruling the global D-dimers market are – Diazyme laboratories Inc., Siemens Healthineers, Abbott, Quiedel Corporation, Biomedica corporations, and Roche Ltd among others.
Market Segmentation and Scope of D-dimer Testing Market